Difficult-to-control asthma — systematic assessment
before escalating · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Most poorly controlled asthma is 'difficult' (modifiable factors) rather than truly 'severe'. A structured assessment of diagnosis, adherence, technique, comorbidities and exposures is mandatory before escalating therapy or labelling refractory disease.
Red flags
- Frequent OCS courses or ICU/near-fatal episodes
- Falling FEV1 or fixed airflow obstruction
- Persistent eosinophilia or systemic features suggesting vasculitis
- Haemoptysis, weight loss or finger clubbing (reconsider diagnosis)
Assessment
Differential diagnosis
- Incorrect diagnosis (COPD, bronchiectasis, heart failure, ILO/VCD)
- Poor adherence to controller therapy
- Poor inhaler technique / wrong device
- Ongoing allergen/occupational/smoke exposure
- Untreated comorbidity (CRSwNP, GORD, OSA, obesity, anxiety)
- Recurrent respiratory infection or ABPA
Investigations
- Spirometry with bronchodilator reversibility; FeNO; peak-flow diary
- Dispensing/prescription collection records to quantify adherence
- Supervised inhaler technique assessment
- Blood eosinophils, total IgE, Aspergillus serology
- Chest X-ray; HRCT if bronchiectasis/ILD suspected
- Screen comorbidities: nasendoscopy for polyps, OSA screen, reflux and mental-health assessment
Management
- Re-confirm that it is asthma with objective evidence of variable airflow obstruction
- Quantify adherence objectively — do not rely on self-report
- Watch the patient use their inhaler and correct technique or switch device
- Identify and remove triggers: smoking, vaping, occupational and domestic allergens
- Systematically treat comorbidities (rhinosinusitis, GORD, obesity, OSA, dysfunctional breathing, anxiety)
- Review medication for asthma-worsening drugs (NSAIDs, non-selective beta-blockers)
- Optimise controller — ensure correct ICS-LABA dose and consider MART/AIR regimen
- Provide a written personalised asthma action plan and self-management education
- Reassess control (ACT/ACQ) after a defined optimisation period
- Only if still uncontrolled with confirmed adherence/technique, refer as true severe asthma for phenotyping/biologics
Drugs & doses
ICS-LABA maintenance-and-reliever (e.g. budesonide-formoterol 200/6 mcg, 1-2 inhalations as needed/maintenance)
Add tiotropium 2.5 mcg (2 puffs) once daily as add-on LAMA
Montelukast 10 mg PO once daily as add-on
Short course prednisolone 40 mg PO once daily for exacerbations
Disposition
Primary care / general respiratory clinic for optimisation; refer to severe-asthma service only after modifiable factors addressed.
Complications & pitfalls
- Unnecessary treatment escalation and steroid toxicity
- Missed alternative diagnosis
- Progressive airway remodelling from under-treatment
- Repeated exacerbations and healthcare utilisation
Exam pearls
- ~50% of 'severe' referrals are difficult-to-control with modifiable factors
- Good adherence often means <50% of prescribed controller is actually taken
- Dysfunctional breathing and ILO frequently coexist and mimic uncontrolled asthma
- Document the optimisation trail before biologic funding applications
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.